Minerva Neurosciences, Inc. Share Price

NASDAQ: NERV

Small Cap

$2.17

+0.03

(+1.40%)

Live

as on September 18, 2025 at 8:14 pm IST

$₹

Minerva Neurosciences, Inc. Stock Performance

as on September 18, 2025 at 8:14 pm IST

Day's Low
Day's High
$2.14
Day's Price Range
$2.2
$2.17
1.38%
Downside
1.38%
Upside
52 Week's Low
52 Week's High
$1.15
52-Week Price Range
$2.91
$2.17
47.00%
Downside
34.11%
Upside

Minerva Neurosciences, Inc. share price movements today

Previous Close: $2.14
Open: $2.17
Volume: 28.5K
Day's Low - High: $2.14 - $2.2
52 Week Low - High: $1.15 - $2.91

Minerva Neurosciences, Inc. Historical Returns

1 Month Return: -12.3 %
3 Month Return: + 18.23 %
1 Year Return: -24.91 %
3 Year Return: -76.59 %
5 Year Return: -92.51 %

Minerva Neurosciences, Inc. Stock Fundamentals & Key Indicators

Check Minerva Neurosciences, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$15.1M

EPS (TTM)

-2.68

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

1.46

Industry PE ratio

-3.9415151515151514

P/B Ratio

1.4595

PEG Ratio

0

EBITDA

-16.2M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-675.09%

Minerva Neurosciences, Inc. Stock Valuation

Track how Minerva Neurosciences, Inc. P/E has moved over time to understand its valuation trends.

Minerva Neurosciences, Inc. in the last 5 years

Overview
Trends

Lowest (17.35x)

March 31, 2021

Industry (-3.94x)

September 18, 2025

Today (1.46x)

September 18, 2025

Highest (62.97x)

December 31, 2020

LowHigh

Today’s Price to Earnings Ratio: 1.46x

Minerva Neurosciences, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Minerva Neurosciences, Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Minerva Neurosciences, Inc.	SELL	$15.1M	-92.51%	1.46	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$60.5B	241.54%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$99.3B	45.88%	27.56	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$60.9B	5.45%	14.49	31.37%

Stock Returns calculator for Minerva Neurosciences, Inc. Stock including INR - Dollar returns

The Minerva Neurosciences, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

1Y
3Y
5Y
7Y
10Y

Minerva Neurosciences, Inc. investment value today

Current value as on today

₹81,094

Returns

₹18,906

(-18.91%)

Returns from Minerva Neurosciences, Inc. Stock

₹23,860 (-23.86%)

Dollar Returns*

₹4,953 (+4.95%)

Analyst Recommendation on Minerva Neurosciences, Inc. Stock

Based on 6 analysts

SELL

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 6 analysts, 50% of analysts recommend a 'SELL' rating for Minerva Neurosciences, Inc.. Average target price of $5

Minerva Neurosciences, Inc. Share Price Target

Get share price movements and forecasts by analysts on Minerva Neurosciences, Inc..

What analysts predicted

56.6%UPSIDE

Target Price

$5

Current Price

$2.17

Analyzed by

6 Analysts

Target

$5.00

Minerva Neurosciences, Inc. target price $5, a slight upside of 56.6% compared to current price of $2.17. According to 6 analysts rating.

Minerva Neurosciences, Inc. Stock's Interest Amongst Investors

Search interest for Minerva Neurosciences, Inc. Stock has increased by 43% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 19, 2025 to September 18, 2025

Change:43% versus previous 30 day period

Minerva Neurosciences, Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	-	-	-	-	0	0	-
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-5	-4	-6	-7	-6	-6	-4	-4	-3	-3
EBITDA	-4	-4	-5	-6	-6	-5	22	-4	-4	-3
Interest Expense	1	2	2	2	2	2	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-6	-6	-7	-9	-8	-8	22	-4	-3	-3
Income Tax Expense	3	2	0	-5	0	0	0	-	-	-
Net Income	-6	-6	-7	-9	-8	-8	22	-4	-3	-3
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-10119.02%	-8889.51%	0.00%

Minerva Neurosciences, Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	41	41	-	-	-	-
Gross Profit	0	0	0	0	0	41	0	0	0	0
Operating Income	-26	-30	-41	-51	-75	1	-45	-25	-23	-21
EBITDA	-26	-29	-40	-50	-74	2	-51	-24	-21	6
Interest Expense	1	1	0	0	1	-	6	7	8	4
Depreciation	-	-	0	0	0	0	0	0	0	0
Income Before Tax	-27	-31	-40	-50	-74	1	-51	-32	-30	1
Income Tax Expense	1	1	-9	1	-2	0	-1	6	0	-
Net Income	-27	-31	-31	-50	-72	1	-49	-32	-30	1
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	-175.31%	4.71%	0.00%	0.00%	0.00%	0.00%

Minerva Neurosciences, Inc. Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-6	-6	-9	-8	-8	5,710,929	-4	-4	-7,011,555
Operating Cash Flow	-3	-6	-5	-6	-3	-14,383,772	-5	-5	-6,114,092
Investing Cash Flow	-	-	-	-	-	-	-	-	-
Financing Cash Flow	19	0	19,584	-	-	-	-	-	-
Change in Cash	15	-58	-5	-6	-3	-4	-5	-5	15,347,888

Minerva Neurosciences, Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-31	-31	-50	-72	1	-49	-32	-30	1
Operating Cash Flow	-25	3	-41	-43	-33	-24	-24	-14	-19
Investing Cash Flow	17	-107	69	14	24	0	0	-	-
Financing Cash Flow	76	47	-3	0	13	60	0	19	-
Change in Cash	68	-56	24	-28	3	35	-24	4	-19,550

Global Institutional Holdings in Minerva Neurosciences, Inc.

Funds	Holdings
Federated Hermes Inc	19.32%
Vanguard Group Inc	3.6%
Renaissance Technologies Corp	1.63%
Geode Capital Management, LLC	1.1%
BlackRock Inc	1.04%

See all

Insights on Minerva Neurosciences, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 111.5% return, outperforming this stock by 188.1%
NO EFFECT
Against Peers
In the last 1 year, Beone Medicines Ltd has given 68.4% return, outperforming this stock by 93.3%
NEGATIVE IMPACT
Price Dip
In the last 1 month, NERV stock has moved down by -12.3%

About Minerva Neurosciences, Inc.

minerva neurosciences, inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of a portfolio of product candidates for the treatment of central nervous system diseases. its lead product candidate is roluperidone, which is in phase iii clinical trial, a compound for the treatment of schizophrenia. the company is also developing seltorexant that has completed phase iib clinical trial for treating insomnia and major depressive disorders; and min-301, which is in pre-clinical trial, a soluble recombinant form of the neuregulin-1b1 protein for the treatment of parkinson's disease. minerva neurosciences, inc. has a license agreement with mitsubishi tanabe pharma corporation for the development and commercialization of the roluperidone worldwide, excluding asia; and co-development and license agreement with janssen pharmaceutica, n.v. for the development of seltorexant. the company was formerly known as cyrenaic pharmaceuticals, inc. and changed its

Organisation	Minerva Neurosciences, Inc.
Headquarters	1500 District Avenue, Burlington, MA, United States, 01803
Industry	Health Technology
CEO	Dr. Remy Luthringer Ph.D.
E-voting on shares	Click here to vote

Key Management of Minerva Neurosciences, Inc.

Name	Title
Dr. Remy Luthringer Ph.D.	Executive Chairman & CEO
Mr. Geoffrey Robin Race F.C.M.A., M.B.A.	President
Mr. Frederick W. Ahlholm CPA	Senior VP, CFO & Secretary
Mr. Joseph Reilly	Senior VP & COO
Mr. William B. Boni	Vice President of Investor Relations & Corporate Communications
Prof. Michael Davidson M.D.	Chief Medical Officer

FAQs

What is Minerva Neurosciences, Inc. share price today?

Minerva Neurosciences, Inc. share price today is $2.17 as on September 18, 2025 at 8:14 pm IST. Minerva Neurosciences, Inc. share today touched a day high of $2.2 and a low of $2.14.

What is the 52 week high and 52 week low for Minerva Neurosciences, Inc. share?

Minerva Neurosciences, Inc. share touched a 52 week high of $2.91 on September 18, 2024 and a 52 week low of $1.15 on April 9, 2025. Minerva Neurosciences, Inc. stock price today i.e. September 18, 2025 at 8:14 pm IST is trending at $2.17,which is 25.43% down from its 52 week high and 88.70% up from its 52 week low.

What is Minerva Neurosciences, Inc.'s market capitalisation today?

Minerva Neurosciences, Inc. market capitalisation is $0.00T as on September 18, 2025 at 8:14 pm IST.

How to invest in Minerva Neurosciences, Inc. Stock (NERV) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Minerva Neurosciences, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Minerva Neurosciences, Inc. Shares that will get you 0.6912 shares as per Minerva Neurosciences, Inc. share price of $2.17 per share as on September 18, 2025 at 8:14 pm IST.

What is the minimum amount required to buy Minerva Neurosciences, Inc. Stock (NERV) from India?

Indian investors can start investing in Minerva Neurosciences, Inc. (NERV) shares with as little as ₹88.114 or $1 (as of September 18, 2025 at 8:37 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹881.14 in Minerva Neurosciences, Inc. stock (as per the Rupee-Dollar exchange rate as on September 18, 2025 at 8:37 pm IST). Based on Minerva Neurosciences, Inc. share’s latest price of $2.17 as on September 18, 2025 at 8:14 pm IST, you will get 4.6083 shares of Minerva Neurosciences, Inc.. Learn more about fractional shares .

What are the returns that Minerva Neurosciences, Inc. has given to Indian investors in the last 5 years?

Minerva Neurosciences, Inc. stock has given -92.51% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?